Actinogen Medical Limited

ASX (AUD): Actinogen Medical Limited (ACW)

Last Price

0.026

Today's Change

+0.002 (8.33%)

Day's Change

0.024 - 0.026

Trading Volume

6,340,377

Overview

Market Cap

80 Million

Shares Outstanding

3 Billion

Avg Volume

10,919,540

Avg Price (50 Days)

0.03

Avg Price (200 Days)

0.04

PE Ratio

-2.60

EPS

-0.01

Earnings Announcement

20-Feb-2025

Previous Close

0.02

Open

0.02

Day's Range

0.024 - 0.026

Year Range

0.02 - 0.099

Trading Volume

6,340,377

Price Change Highlight

1 Day Change

8.33%

5 Day Change

4.00%

1 Month Change

-3.70%

3 Month Change

8.33%

6 Month Change

0.00%

Ytd Change

25.53%

1 Year Change

9.84%

3 Year Change

-82.85%

5 Year Change

-43.99%

10 Year Change

-26.31%

Max Change

-96.05%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment